SCHEMBL6014404

SCHEMBL6014404

CN(C)c1ccc(-c2cnc(-c3ccc(S(=O)(=O)N4CCOCC4)cc3)o2)cc1

nearest known ligand 0.48

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
POLB P06746 4/20 0.48
GAA P10253 3/20 0.48
KMT2A Q03164 2/20 0.48
MEN1 O00255 1/20 0.48
HTR6 P50406 1/20 0.48
ALDH1A1 P00352 3/20 0.47
KDM4E B2RXH2 2/20 0.47
HSD17B10 Q99714 2/20 0.47
USP2 O75604 1/20 0.47
SMN1; SMN2 Q16637 4/20 0.44
LMNA P02545 3/20 0.44
HPGD P15428 1/20 0.43
TP53 P04637 2/20 0.43
MAPT P10636 2/20 0.43
CA1 P00915 2/20 0.43
BLM P54132 1/20 0.43
CA12 O43570 1/20 0.43
CA9 Q16790 1/20 0.43
CA2 P00918 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6014359 0.89 SMN1; SMN2 (0.48) POLBKMT2AMEN1HTR6ALDH1A1
SCHEMBL6014402 0.88 HTR6 (0.58) POLBHTR6ALDH1A1LMNATP53
SCHEMBL4879804 0.86 GAA (0.67) POLBGAAKMT2AMEN1ALDH1A1
SCHEMBL6014725 0.81 CA1 (0.50) POLBGAAKMT2AMEN1HTR6
SCHEMBL20356911 0.80 CA1 (0.49) POLBGAAKMT2AMEN1HTR6
SCHEMBL6014360 0.80 CA1 (0.51) POLBGAAKMT2AMEN1HTR6
SCHEMBL12231198 0.80 CA1 (0.51) POLBGAAKMT2AMEN1HTR6
SCHEMBL6014518 0.78 NPC1 (0.50) POLBGAAKMT2AMEN1HTR6
SCHEMBL6014446 0.78 CA1 (0.68) POLBKMT2AMEN1HTR6CA1
SCHEMBL6870234 0.77 HTR6 (0.53) KMT2AMEN1HTR6ALDH1A1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7078406-B2 Substituted diphenyloxazoles, the synthesis thereof, and the use thereof as fluorescence probes JOHNSON & JOHNSON PHARMACEUTICAL RESEARCH & DEVELOPMENT, L.L.C. (US) 2006-07-18 US disclosed
US-20040248851-A1 Substituted diphenyloxazoles, the synthesis thereof, and the use thereof as fluorescence probes Life Technologies Corporation 2004-12-09 US disclosed
US-6815445-B2 FOR USE AS FLUORESCENCE DYES AND PROBES Life Technologies Corporation 2004-11-09 US disclosed
EP-1442027-A1 SUBSTITUTED DIPHENYLOXAZOLES, THE SYNTHESIS THEREOF, AND THE USE THEREOF AS FLUORESCENCE PROBES 3-DIMENSIONAL PHARMACEUTICALS, INC. (US) 2004-08-04 EP disclosed
US-20030105111-A1 Substituted diphenyloxazoles, the synthesis thereof, and the use thereof as fluorescence probes 3-DIMENSIONAL PHARMACEUTICALS, INC. 2003-06-05 US disclosed
WO-2003031419-A1 SUBSTITUTED DIPHENYLOXAZOLES, THE SYNTHESIS THEREOF, AND THE USE THEREOF AS FLUORESCENCE PROBES 3-DIMENSIONAL PHARMACEUTICALS, INC. (US) 2003-04-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040248851-A1 Substituted diphenyloxazoles, the synthesis thereof, and the use thereof as fluorescence probes DHFR, FPR1, CYP1A1 POLB 2158/4885GAA 2587/4885KMT2A 1404/4885
US-20030105111-A1 Substituted diphenyloxazoles, the synthesis thereof, and the use thereof as fluorescence probes DHFR, FPR1, CYP1A1 POLB 2158/4885GAA 2587/4885KMT2A 1404/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.